341 results
8-A12G/A
EX-1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Dec 98
Registration of securities (amended)
12:00am
.
(b) The phrase "a majority of Continuing Directors then in
office" which appears twice in subsection (h) shall be replaced … which reads "a majority of Continuing Directors
then in office" in the first sentence of subsection (a) shall be
replaced
S-4
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Jul 98
Registration of securities issued in business combination transactions
12:00am
the number of shares thereof then outstanding) by the affirmative
vote of the holders of the majority of the shares of stock of this corporation
entitled … of the following paragraph (a) or paragraph (b) are met:
a. The Business Combination shall have been approved by a
majority
8-A12G
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
30 Sep 96
Registration of securities
12:00am
be redeemed by the Company at $.01 per Right
within ten days (or on such later date as may be determined by a majority of
the Board of Directors, excluding … (or such later date as may be determined by a majority of the Board of
Directors, excluding directors affiliated with the Acquiring Person, as defined
below
8-K
EX-3.1
kt02ao8kdv8jted5sv
12 Apr 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
05405vizzp3
9 Aug 18
Entry into a Material Definitive Agreement
9:05am
S-4
EX-3.3
luxcy5e4959nt eq
9 Jul 98
Registration of securities issued in business combination transactions
12:00am
8-K
EX-3.1
8j4e6f
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm
DEFA14A
8gxt t3v65pi5lj
9 May 24
Additional proxy soliciting materials
4:11pm
8-K
EX-3.1
mogffpr 20v97wln
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-A12G
EX-99.1
mlcdbc92ke4
30 Sep 96
Registration of securities
12:00am
S-3/A
EX-10.1
r7jypvc37l
22 Oct 96
Shelf registration (amended)
12:00am
SC TO-T
EX-99
bmy amza17uyvqw6gy
31 Aug 20
Third party tender offer statement
8:46am